We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Injectable Adhesive Hydrogel Uses Harmless Visible Light for Bone Regeneration

By HospiMedica International staff writers
Posted on 01 Jan 2025

Bone defects, which can result from trauma, infections, or congenital conditions, are becoming increasingly prevalent, particularly in aging populations. More...

Traditional treatments often involve bone grafts combined with serum or bioadhesives to fill the defect. However, current injectable hydrogels face several challenges, such as difficulty in maintaining their shape within the body and insufficient adhesive strength. Additionally, conventional methods using bone grafts and adhesive materials often fail to achieve both "bone regeneration" and "adhesion" simultaneously. A new study has led to the development of an innovative injectable adhesive hydrogel designed for bone regeneration, which uses harmless visible light to facilitate both cross-linking and mineralization without the need for bone grafts.

This new hydrogel system, developed by scientists at Pohang University of Science and Technology (POSTECH, Gyeong Buk, Korea), uses visible light—safe for human tissues—to trigger cross-linking, a process where the hydrogel’s components bond and harden. Simultaneously, the system encourages the formation of bone-building minerals like calcium and phosphate within the hydrogel, boosting mineralization. While earlier research explored light-based methods for similar applications, challenges arose, including the need to separately prepare and mix bone grafts and adhesive materials, as well as weak bonding of the components, which led to degradation over time. The newly developed hydrogel precursor is made from alginate (a natural polysaccharide derived from brown algae), RGD peptide-containing mussel adhesive protein, calcium ions, phosphonodiols, and a photoinitiator.

The coacervate-based formulation, which is immiscible in water, ensures that the hydrogel retains its shape and position after injection into the body. Upon exposure to visible light, the hydrogel undergoes cross-linking, and amorphous calcium phosphate—a material that serves as a bone graft—is simultaneously formed. This process eliminates the need for separate bone grafts or adhesives, enabling the hydrogel to provide both bone regeneration and adhesion. In experiments with animal models that had femoral bone defects, the hydrogel was successfully injected, adhered securely, and effectively delivered the necessary components for bone regeneration. These findings were published in Biomaterials, marking a significant advancement in the field.

"The injectable hydrogel system for bone regeneration developed by our research team represents an innovative alternative to conventional complex treatments for bone diseases and will greatly advance bone tissue regeneration technology," said POSTECH's Professor Hyung Joon Cha who led the research team.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.